Piperazine sulfonamides as DPP-IV inhibitors: Synthesis, induced-fit docking and in vitro biological evaluation

Publié en ligne: 03 avr. 2021

Pages: 631 - 643

Accepté: 20 oct. 2020

DOI: https://doi.org/10.2478/acph-2021-0034

Mots clés

piperazine sulfonamide, dipeptidyl peptidase-IV inhibitor, diabetes mellitus, induced-fit docking

© 2021 Reema Abu Khalaf et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.